Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, December 18, 2014

In A Quiet Week For IPOs, Bellicum Pharmaceuticals Stands Out

The BLCM IPO is set to price Wednesday night, 12.17.2014; lead underwriters are Piper Jaffray, Citibank, and Jefferies. BLCM is focused on developing new types of cellular immunotherapies for various types of hematological cancers and solid tumors, as well as orphan inherited blood disorders.

http://ift.tt/1z9fpkU
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts